Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 13/20 | 0.65 |
| ▸ | ECE1 | P42892 | 1/20 | 0.62 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.62 |
| ▸ | KISS1R | Q969F8 | 6/20 | 0.61 |
| ▸ | VIPR1 | P32241 | 1/20 | 0.59 |
| ▸ | CCKBR | P32239 | 1/20 | 0.59 |
| ▸ | GCGR | P47871 | 1/20 | 0.58 |
| ▸ | GIPR | P48546 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30506383 | 0.96 | GLP1R (0.69) | GLP1RECE1MUS81VIPR1CCKBR | |
| SCHEMBL30167097 | 0.95 | GLP1R (0.62) | GLP1RECE1MUS81KISS1R | |
| SCHEMBL29358496 | 0.92 | GLP1R (0.68) | GLP1RECE1MUS81KISS1RVIPR1 | |
| SCHEMBL30128808 | 0.92 | GLP1R (0.65) | GLP1RECE1MUS81KISS1RGCGR | |
| SCHEMBL31688342 | 0.92 | GLP1R (0.63) | GLP1RECE1MUS81KISS1RGCGR | |
| SCHEMBL30209672 | 0.91 | GLP1R (0.63) | GLP1RECE1MUS81KISS1RVIPR1 | |
| SCHEMBL30986899 | 0.90 | GLP1R (0.71) | GLP1RECE1MUS81KISS1RCCKBR | |
| SCHEMBL29427174 | 0.90 | MAGI3 (0.59) | GLP1RECE1MUS81KISS1R | |
| SCHEMBL29694498 | 0.90 | GLP1R (0.60) | GLP1RECE1MUS81KISS1RCCKBR | |
| SCHEMBL30435720 | 0.90 | PTH1R (0.64) | GLP1RECE1MUS81 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4617282-A1 | MEMBRANE FUSION INHIBITOR FOR INHIBITING AIDS VIRUS AND DRUG-RESISTANT STRAIN THEREOF, AND PHARMACEUTICAL USE THEREOF | Institute Of Pathogen Biology, Chinese Academy Of Medical Sciences (CN) | 2025-09-17 | — | — | EP | claimed |
| WO-2024099428-A1 | MEMBRANE FUSION INHIBITOR FOR INHIBITING AIDS VIRUS AND DRUG-RESISTANT STRAIN THEREOF, AND PHARMACEUTICAL USE THEREOF | 中国医学科学院病原生物学研究所 | 2024-05-16 | — | — | WO | claimed |
| EP-4617282-A1 | MEMBRANE FUSION INHIBITOR FOR INHIBITING AIDS VIRUS AND DRUG-RESISTANT STRAIN THEREOF, AND PHARMACEUTICAL USE THEREOF | Institute Of Pathogen Biology, Chinese Academy Of Medical Sciences (CN) | 2025-09-17 | — | — | EP | disclosed |
| WO-2024099428-A1 | MEMBRANE FUSION INHIBITOR FOR INHIBITING AIDS VIRUS AND DRUG-RESISTANT STRAIN THEREOF, AND PHARMACEUTICAL USE THEREOF | 中国医学科学院病原生物学研究所 | 2024-05-16 | — | — | WO | disclosed |
| CN-115724919-B | Novel membrane fusion inhibitor for strongly inhibiting AIDS virus and drug-resistant strain thereof and pharmaceutical application thereof | 中国医学科学院病原生物学研究所 | 2023-06-27 | — | — | CN | disclosed |
| US-11680086-B2 | Lipopeptide for potently inhibiting HIV, derivative thereof, pharmaceutical composition thereof and use thereof | Shanxi Kangbao Biological Product Co., Ltd. (CN) | 2023-06-20 | — | — | US | disclosed |
| CN-115724919-A | Novel membrane fusion inhibitor for strongly inhibiting AIDS virus and drug-resistant strains thereof and pharmaceutical application thereof | 中国医学科学院病原生物学研究所 | 2023-03-03 | — | — | CN | disclosed |
| CN-111944025-B | HIV (human immunodeficiency Virus) membrane fusion inhibitor lipopeptide and pharmaceutical application thereof | 中国医学科学院病原生物学研究所 | 2022-06-07 | — | — | CN | disclosed |